Rapid Diagnostic & Assessment Pathways
Early diagnosis, assessment of cancers and timely access to treatment are important factors for improving cancer survival and quality of life post treatment. The Alliance is implementing Rapid Diagnostic & Assessment Pathways for Lung, Prostate and Colorectal cancers.
The aim is:
• for a diagnosis, or
• to rule out cancer as quickly as possible so that patients receive the right treatment or to put patients’ minds at rest where cancer is not diagnosed
If colorectal cancer is treated early 95% of men and around 100% of women with stage 1 bowel cancer will survive for 5+ years
In 2013, Lung cancer was responsible for 22% of cancer deaths in our area
Only 21% of cancers in our area are diagnosed at stage 1 and 2
Radiotherapy is the use of radiation to treat cancer. It destroys cancer cells in the area where it is given and can be used to try to cure cancer, reduce the chance of cancer coming back, or to help relieve symptoms.
In 2019, a Radiotherapy Network was established to bring together provider representatives from across Humber, Coast and Vale, South Yorkshire and Bassetlaw, and West Yorkshire and Harrogate to help reduce variation and improve cancer outcomes for patients. By working collaboratively, regional representatives are developing and maintaining up-to-date clinical guidelines and patient pathways, reviewing local data and metrics, and leading on rapid change.
Humber, Coast and Vale Cancer Alliance is a member of Operational Delivery Network (ODN), which governs the work of the Radiotherapy Network to ensure the delivery of its annual work programme.
The aims of the Radiotherapy Network work programme are to:
- Improve access to modern, advanced and innovative radiotherapy techniques, enabling more patients to benefit from cutting-edge technology and treatment
- Improve the experience of care by ensuring that patients will be managed by an experienced multi-professional tumour specific subspecialist team able to provide holistic care
- Increase participation in research and clinical trials in England, aiding faster development of new treatments and helping to drive the development of clinical services
- Reduce variation in quality by adopting standardised best practice protocols, thereby improving patient outcomes
- Reduce variation in equipment utilisation through changing operating arrangements, clinical practice and equipment replacement
You can read the specifications of the new services and more information about how NHS England is modernising radiotherapy services here.
Clincial Delivery Groups
Each of Humber, Coast and Vale Cancer Alliance’s Clinical Delivery Groups (CDGs) provides an opportunity for clinical leaders to discuss best practice, share challenges, and reduce variation in practice.
The groups support the delivery of large scale transformational change across the system, bringing together individuals from organisations and localities within our footprint, agreed programme workstreams, patients and the public, neighbouring cancer alliances, and other groups deemed appropriate by the chair to collaboratively develop new ways of working for the overall benefit of the population, particularly those affected by cancer.
CDGs are the source of expert clinical and professional opinion from which advice is sought on a wide range of cancer services issues. The groups adopt an evidence-based approach, incorporating national best-practice guidance, to ensure an improvement in common standards and pathways to uphold the Cancer Alliance vision of “achieving world-class cancer outcomes for our communities”.